Health & Fitness

According to FutureWise analysis, the market for Animal Genetics was estimated to be US$ 5.9 billion in 2023 and is expected to grow at a CAGR of 6.7% over the forecast period of 2023-2031. Animal genetics is a branch of veterinary medicine that focuses on studying genes and their effects on living organisms. The genetic information contained within an organism's DNA acts as a biological blueprint for its appearance, function, and survival, playing a significant role in defining its similarities and differences with other organisms. This field relies on fundamental genetic principles and concepts, utilizing methods such as hybrid analysis, cytological studies, population genetics, ontogenetics, mathematical-statistical approaches, and twin studies. Livestock genetics are particularly important in influencing animal production and health. Due to the large number of chromosomes present in animals, traits are often inherited independently. The primary method for investigating the ... Continue reading →

According to FutureWise analysis the market for healthcare revenue cycle management in 2023 was US$ 29.4 billion, and is expected to reach US$ 81.09 billion by 2031 at a CAGR of 13.52%. Healthcare revenue cycle management is all about how healthcare organizations handle the financial side of things, particularly when it comes to billing and getting paid for services. This process starts with patient registration, where information is collected when patients arrive. Next is charge capture, which involves recording all the services provided during the visit. After that, claims submission takes place, where bills are sent to insurance companies for payment. Once payments are received, they are recorded in the payment posting step. Finally, denial management comes into play, addressing any claims that insurance companies didn’t pay. Each of these steps is crucial for ensuring that healthcare providers are compensated for the care they deliver. Patient registration is the initial ... Continue reading →

According to FutureWise analysis, the market for Botox was US$ 6,269.1 million in 2022, and is expected to grow at a CAGR of 7.9% over the forecast period of 2023-2031. Botox, also known as botulinum toxin, is a neurotoxic protein derived from the bacteria Clostridium botulinum. It is commonly used for both cosmetic and medical purposes. In cosmetic applications, Botox is primarily used to treat wrinkles and fine lines on the face. Medically, it can address conditions such as muscle spasms, migraines, and excessive sweating. When used for aesthetic purposes, Botox is injected directly into the muscles responsible for causing wrinkles and fine lines. The toxin works by blocking the signals that nerves send to these muscles, leading to muscle relaxation. As a result, the skin appears smoother, and the visibility of wrinkles and fine lines is reduced. Botox is commonly used to treat forehead lines, crow's feet, and frown lines. It is also used to lift the eyebrows and to reduce the ... Continue reading →

According to FutureWise analysis, the market for clinical reference laboratory in 2023 was US$ 234.5 billion, and is expected to reach US$ 368.71 billion by 2031 at a CAGR of 5.80%. The clinical reference laboratory market plays a vital role in the healthcare system by providing essential diagnostic tests that enable healthcare professionals to deliver optimal care to their patients. These laboratories are integral to the healthcare community as they perform a diverse array of tests using various sample types, including blood, urine, tissue, and genetic material. With advancements in technology and increasing demand for accurate diagnostics, these laboratories continuously innovate to improve testing methods and turnaround times. Additionally, their role in research and development contributes significantly to the advancement of medical science and public health initiatives. Leveraging cutting-edge technology and specialized techniques, clinical reference laboratories extract critical ... Continue reading →

According to FutureWise analysis the market for Plasmid DNA Manufacturing in 2023 was US$ 1.52 billion, and is expected to reach US$ 5.66 billion by 2031 at a CAGR of 17.90%. Plasmid DNA plays a vital role in today's healthcare industry. It can be utilized directly for therapeutic purposes, such as gene therapy and vaccine antigen production, as well as indirectly for various research applications like gene mapping and cloning. These applications can aid in the prevention of diseases such as cystic fibrosis and Huntington's disease. Plasmid DNA serves as a crucial starting material for transient transfection, which is used to construct viral vector structures, including lentiviruses and adeno-associated viruses (AAV). Additionally, it is important for developing transient proteins, such as monoclonal antibodies. Gene therapy is an emerging medical field that holds the promise of innovative treatments for individuals suffering from a wide range of conditions. Due to its diverse ... Continue reading →

According to FutureWise analysis the market for psa test in 2023 was US$ 3.8 billion, and is expected to reach US$ 6.3 billion by 2031 at a CAGR of 10.2%. The Prostate-Specific Antigen (PSA) test is a blood test commonly used for screening prostate cancer. This test measures the level of prostate-specific antigen, a protein produced by both cancerous and noncancerous cells in the prostate—a small gland located below the bladder in men. While a small amount of PSA is typically present in the bloodstream, elevated levels can indicate the presence of prostate cancer. However, it's important to note that PSA levels can also rise due to other conditions, such as benign prostatic hyperplasia (enlarged prostate) or prostatitis (inflammation of the prostate), making the interpretation of high PSA scores complex. In the coming years, the PSA test market is expected to grow significantly, driven by an increasing elderly population. Prostate cancer screening offers several ... Continue reading →

According to FutureWise analysis the market for Mammalian Transient Protein Expression in 2023 was US$ 0.69 billion, and is expected to reach US$ 1.35 billion by 2031 at a CAGR of 8.72%. The mammalian transient protein expression market is a key area within the biotechnology and pharmaceutical industries. It specializes in producing proteins using mammalian cells, which play a crucial role in research and the development of new therapies. This market is becoming increasingly important because of the rising demand for proteins in various applications like drug discovery, vaccine development, and the creation of monoclonal antibodies. In simpler terms, this means that scientists are using techniques that allow them to quickly produce proteins in living cells. These proteins can then be used to test new drugs or to create vaccines that help fight diseases. Monoclonal antibodies, in particular, are essential for treating various conditions, including some types of cancer and autoimmune ... Continue reading →

According to FutureWise analysis, the market for Orthopedic Footwear in 2023 was US$ 3.95 billion and is expected to reach US$ 8.36 billion by 2031 at a CAGR of 9.80%. Orthopedic footwear is designed to help with various foot problems and medical conditions. Some common issues that these shoes can address include plantar fasciitis, hammertoes, blisters, bunions, foot injuries, heel spurs, and alignment problems with your legs and feet, especially for those with diabetes. These special footwear provide important support for the muscles, tendons, and joints in your feet and ankles. By doing so, they help correct the way your body is positioned, which can lead to less pain when walking or standing. Not only do orthopedic shoes offer better support, but they also help keep your feet healthy by preventing discomfort and other issues. Orthopedic footwear come with features like adjustable buckles, Velcro straps, and custom insoles, which can be really helpful for relieving problems such as ... Continue reading →

The global market was projected accounts for USD 27,960.0 Mn in 2021 and to grow at a CAGR of 29.4% through 2032. The global market is estimated to grow 1.63x between 2024 and 2032 creating an absolute $ opportunity of more than USD 2,218.8 Mn. In 2021, the Extended Reality (XR) Market has decline and witnessed a Y-o-Y of 5.1%, compared to 7.5% of Y-o-Y in 2020. Based on Device Type, the market is segmented into AR devices, VR devices, MR devices. Among Device Type, VR devices accounts for nearly 51.6% of the share in 2022-23 in the market with CAGR of 28.6% during the forecast period. Extended Reality (XR) is a relatively new concept that encompasses advanced technologies like Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR). XR offers mobile solutions that are easily accessible on most electronic devices. It serves as an umbrella term for all computer-generated environments that blend the virtual and physical worlds, providing users with an immersive experience. ... Continue reading →

According to FutureWise analysis the market for Lateral Flow Assays in 2023 was US$ 9.59 billion, and is expected to reach US$ 14.08 billion by 2031 at a CAGR of 4.92%. Lateral flow refers to a kind of immunoassay that employs a paper-based strip to identify the presence of a specific target analyte, such as a virus or a protein biomarker, within a biological sample. A sample is generally applied to one end of the strip, which is equipped with various antibodies that attach to the target analyte if it is present. The strip is then analyzed visually, where the emergence of a line signifies the presence of the analyte. The lateral flow market encompasses a range of applications, including infectious disease testing, pregnancy testing, drug testing, and others. Lateral flow assays, also known as lateral flow immunochromatographic assays, are used to determine the presence (or absence) of a target analyte in a sample. These tests, often utilized in hospitals and ... Continue reading →